Bank Of America Corp Navidea Biopharmaceuticals, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.08 - $0.29 $34 - $123	425 Added 36.05%	1,604 $0
Q4 2022 Feb 10, 2023	SELL	$0.18 - $0.3 $97 - $162	-543 Reduced 31.53%	1,179 $0
Q1 2022 May 16, 2022	SELL	$0.72 - $1.2 $138 - $231	-193 Reduced 10.08%	1,722 $1,000
Q4 2021 Feb 08, 2022	BUY	$1.0 - $1.82 $93 - $169	93 Added 5.1%	1,915 $2,000
Q3 2021 Nov 15, 2021	SELL	$1.53 - $1.85 $10 - $12	-7 Reduced 0.38%	1,822 $3,000
Q2 2021 Sep 13, 2021	BUY	$1.55 - $2.15 $2,834 - $3,932	1,829 New	1,829 $3,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.